510(k) K082121
K082121 is an FDA 510(k) premarket notification submitted by Eps Bio Technology Corp. for the device "EASYMAX SELF MONITORING GLUCOSE TEST SYSTEM, MODEL # EPS08005". The FDA issued a decision of Substantially Equivalent on September 17, 2008. The device falls under product code CGA (Glucose Oxidase, Glucose), a Class II device regulated under 21 CFR 862.1345. Eps Bio Technology Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 17, 2008
- Date Received
- July 28, 2008
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Glucose Oxidase, Glucose
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type